All News
Diagnostics beyond metros: Bridging the gap
Despite challenges, diagnostics in tier 2 and 3 cities are growing through PPPs and technology adoption
Read MoreThe role of indigenous data in enhancing AI’s impact in healthcare
Shashi Shekhar Vempati, Co-Founder, DeepTech for Bharat Foundation explains how Indigenous data holds the key to making AI solutions more relevant and effective
Read MoreAlteplase Also Shows Its Mettle for Late Strokes in HOPE Trial
(MedPage Today) -- LOS ANGELES -- The HOPE trial made another case for extending the therapeutic window for IV thrombolysis in acute ischemic stroke, potentially widening the pool of people eligibl
Read MoreHow Many People Ditch New Weight-Loss Drugs?
(MedPage Today) -- You passed medical training, now see if you can pass our weekly quiz
Read MoreSTAT+: What are indirect research costs? A quick explainer in light of NIH’s sweeping policy change
National Institutes of Health slashed overhead costs allowed under its grants to match private foundations, but the two don't account for expenses in the same way.
Read MoreTrump administration to cut billions in medical research funding
National Institutes of Health said the $4bn in cuts will affect ‘indirect’ funding of buildings, equipment and staffThe Trump administration is cutting billions of dollars in medical research fund
Read MoreOpinion: Indirect research costs are complicated, wonky — and crucial to science
After two decades of work in biomedical research policy, there is no topic Carrie Wolinetz hates talking about more than indirect costs. She’s addressing them now because they are crucial.
Read MoreHealth minister Andrew Gwynne sacked over offensive WhatsApp comments
MP also suspended from Labour party after exposure of messages in which he said he hoped for pensioner’s deathA Labour minister has been sacked and suspended from the party after messages were expos
Read MoreRisankizumab Tops Competitor for Clinical Remission in Moderate-to-Severe CD
(MedPage Today) -- SAN FRANCISCO -- More adults with moderate-to-severe Crohn's disease (CD) reached clinical remission after 6 months on risankizumab (Skyrizi) versus ustekinumab (Stelara), accord
Read MorePutting Diabetes Into Remission; Does Prehabilitation Work?
(MedPage Today) -- TTHealthWatch is a weekly podcast from Texas Tech.
Read More